Early Diagnosis of Pancreatic Cancer-Network Collaborative Studies
- Abbreviated Name
- Early Diagnosis of Pancreatic Cancer-Network Collaborative Studies
- Lead Investigator
- Hollingsworth, Michael — University of Nebraska Medical Center
- Coordinating Investigator
- Hollingsworth, Michael — University of Nebraska Medical Center
- Involved Investigators
Abstact
Aims
Specific Aim 1) Utilize newly developed and to be developed antibodies against the mucin core proteins MUC1, MUC4, and MUC17 to develop an improved serum assay for pancreatic adenocarcinoma. Specific Aim 2) Develop and utilize a set of monoclonal antibodies that recognize serum forms of distinct mucin core proteins, utilize these to improve the diagnostic capability of the CA 19-9 type tests for nonmalignant, premalignant and malignant lesions of the pancreas, and evaluate the capability of the test to discriminate pancreatic cancer from other adenocarcinomas.
Analytic Method
Biomarkers
- No biomarkers available at this time for this protocol
Data Collections
- No data available at this time for this protocol
- Protocol ID
- 196
- Protocol Type
- Collaboration
- Field of Research
- UNKNOWN
- Collaborative Group
- G.I. and Other Associated Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of pancreas